S. A. Shellard

430 total citations
8 papers, 359 citations indexed

About

S. A. Shellard is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, S. A. Shellard has authored 8 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in S. A. Shellard's work include DNA Repair Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Chemotherapy-induced organ toxicity mitigation (2 papers). S. A. Shellard is often cited by papers focused on DNA Repair Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Chemotherapy-induced organ toxicity mitigation (2 papers). S. A. Shellard collaborates with scholars based in United Kingdom, United States and Sweden. S. A. Shellard's co-authors include Bridget T. Hill, Louise K. Hosking, Anne Marie J. Fichtinger-Schepman, Philip Bedford, M. Claire Walker, John R. Masters, John S. Lazo, Richard D. H. Whelan, H. Thomas Rupniak and Denise Sheer and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

S. A. Shellard

8 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. A. Shellard United Kingdom	7	230	139	50	42	39	8	359
Hiroyuki Kouji Japan	12	331 1.4×	95 0.7×	27 0.5×	23 0.5×	47 1.2×	29	461
Pushpa Singh India	12	190 0.8×	86 0.6×	15 0.3×	67 1.6×	58 1.5×	21	366
Makiko Hirose Japan	6	339 1.5×	171 1.2×	31 0.6×	7 0.2×	46 1.2×	9	484
Maribel Lara‐Chica Spain	10	169 0.7×	61 0.4×	23 0.5×	9 0.2×	63 1.6×	13	301
Caroline D. Scatena United States	9	509 2.2×	335 2.4×	27 0.5×	12 0.3×	66 1.7×	12	696
S H Chambers United Kingdom	8	241 1.0×	73 0.5×	13 0.3×	15 0.4×	62 1.6×	10	351
Thippeswamy Gulappa United States	10	211 0.9×	72 0.5×	19 0.4×	15 0.4×	49 1.3×	14	324
Victor P. Ghidu United States	6	373 1.6×	99 0.7×	47 0.9×	20 0.5×	20 0.5×	7	466
Takeo Terasaki United Kingdom	10	255 1.1×	161 1.2×	23 0.5×	19 0.5×	39 1.0×	19	362
Elangovan Thavathiru United States	12	219 1.0×	92 0.7×	21 0.4×	23 0.5×	59 1.5×	16	371

Countries citing papers authored by S. A. Shellard

Since Specialization

Citations

This map shows the geographic impact of S. A. Shellard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Shellard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Shellard more than expected).

Fields of papers citing papers by S. A. Shellard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Shellard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Shellard. The network helps show where S. A. Shellard may publish in the future.

Co-authorship network of co-authors of S. A. Shellard

This figure shows the co-authorship network connecting the top 25 collaborators of S. A. Shellard. A scholar is included among the top collaborators of S. A. Shellard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. A. Shellard. S. A. Shellard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Shellard, S. A., et al.. (1994). Characterization of the unusual expression of cross resistance to cisplatin in a series of etoposide-selected resistant sublines of the SuSa testicular teratoma cell line. Biochemical Pharmacology. 47(5). 775–779. 3 indexed citations

Hill, Bridget T., Kevin J. Scanlon, Johan Hansson, et al.. (1994). Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. European Journal of Cancer. 30(6). 832–837. 40 indexed citations

Shellard, S. A., et al.. (1993). Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines. Anti-Cancer Drugs. 4(4). 491–500. 49 indexed citations

Shellard, S. A., Louise K. Hosking, & Bridget T. Hill. (1991). Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.. PubMed. 51(17). 4557–64. 38 indexed citations

Shellard, S. A., et al.. (1989). Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. British Journal of Cancer. 60(3). 288–290. 42 indexed citations

Bedford, Philip, Anne Marie J. Fichtinger-Schepman, S. A. Shellard, et al.. (1988). Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.. PubMed. 48(11). 3019–24. 106 indexed citations

Hill, Bridget T., Richard D. H. Whelan, Louise K. Hosking, et al.. (1988). Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro.. PubMed. 177–81. 24 indexed citations

Hill, Bridget T., Richard D. H. Whelan, Louise K. Hosking, et al.. (1987). Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. International Journal of Cancer. 39(2). 219–225. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact